Publications

Stay up to date on PsychoGenics’ latest research, press releases, and industry developments in preclinical drug discovery. Combine our expertise with yours to spark the translational power of your next CNS breakthrough.

PUBLICATION

A systematic assessment of robustness in CNS safety pharmacology.

September 22, 2025
Read More
PUBLICATION

Nutritional supplement containing a nuclear fraction of bovine thymus gland increases the circulating levels of spermidine

September 10, 2025
Read More
PUBLICATION

Biomarker Analysis of Orally Dosed, Dual Active, Matrix Metalloproteinase (MMP)-2 and MMP-9 Inhibitor, AQU-118, in the Spinal Nerve Ligation (SNL) Rat Model of Neuropathic Pain

February 1, 2019
Read More
PUBLICATION

Myelinated axons fail to develop properly in a genetically authentic mouse model of Charcot-Marie-Tooth disease type 2E

October 1, 2018
Read More
PUBLICATION

Differences in Synaptic Dysfunction Between rTg4510 and APP/PS1 Mouse Models of Alzheimer’s Disease

August 1, 2018
Read More
PUBLICATION

Synergistic antileukemic therapies in NOTCH1-induced T-ALL.

October 12, 2017
Read More
PUBLICATION

Quantitative Tyrosine Phosphoproteomics of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-treated Lung Adenocarcinoma Cells Reveals Potential Novel Biomarkers of Therapeutic Response

October 11, 2017
Read More
PUBLICATION

High-throughput validation of ceRNA regulatory networks

October 10, 2017
Read More
PUBLICATION

Novel Hybrid Phenotype Revealed in Small Cell Lung Cancer by a Transcription Factor Network Model That Can Explain Tumor Heterogeneity

August 28, 2017
Read More
PUBLICATION

Bone morphogenetic protein and Notch signalling crosstalk in poor-prognosis, mesenchymal-subtype colorectal cancer

May 1, 2017
Read More
PUBLICATION

Phosphodiesterase 10 inhibition improves cortical – basal ganglia function in Huntington’s Disease models.

December 26, 2016
Read More